Pemphigus Market Size was valued at USD 1.58 Billion in 2023. The Global Pemphigus industry is projected to grow from USD 1.67 Billion in 2024 to USD 3.21 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.57% during the forecast period (2024 - 2032). Pemphigus is an inflammatory illness that affects the immune system.
It is a collection of uncommon skin conditions that produce blisters and ulcers in the mouth, skin, and genitals, among other symptoms. In pemphigus, the immunological system creates antibodies that are wrongly directed against healthy tissue in the skin and mucosa. It may arise as a secondary effect of medicine after eating certain blood pressure medications.
The rising incidence of cancer, increased tobacco usage, addictive personality, increased pollution, growing elderly population, and increased knowledge about oral hygiene are all expected to contribute to the development of this market in the coming years. Pelagius condition affects around 2,500 persons in the United States, according to the International Pemphigus and Pemphigoid Foundation (IPPF). In addition, it was discovered that there were 40,000 to 50,000 cases of pemphigus in the globe in the year 2017.
This report contains all the information on the global pemphigus market analysis and its strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other essential factors. And a detailed analysis of the pemphigus market forecast for 2027 is also included in the report.
Covid 19 Analysis
COVID19 had a significant impact on a wide range of industries, including restrictions on shipping and logistics, as well as foreign bans. In addition, the outbreak created a situation where both commercial and industrial enterprises were shut down for an abnormally long period of time. This resulted in financial instability and has affected the pemphigus market value as well.
Pemphigus market growth is being driven by a rise in the number of instances of uncommon autoimmune illnesses, as well as higher consumption of blood pressure drugs, chelating compounds, and pyrazolones. Pemphigus market growth is further boosted by greater exposure to UV radiation, psychological anguish, and thermal burns, all of which contribute to the disease's spread.
In addition to advancements in the management of autoimmune illnesses, an increasing number of people suffering from autoimmune system illnesses, including myasthenia gravis and thymoma, throughout the globe will propel the worldwide pemphigus market forward.
Although several factors are driving the market, considerations such as rapidly increasing health expenditures, an increase in the total count of research and innovation, an unfavourable cost recovery environment, and strict regulations policies may limit the market's growth during the period of assessment.
During the time under consideration, an unfavourable cost recovery environment, as well as rigorous regulatory rules, may create challenges for the market's expansion.
In terms of market share, Europe is trailing behind the United States. It is predicted that the existence of nations such as France, the United Kingdom, Germany, and others would help to propel the growth in the region ahead. The increasing number of persons of Mediterranean heritage in these two locations is causing a substantial growth in the percentage of people afflicted by the illness within those two areas.
The Americas has the capacity to rise at a compound annual growth rate (CAGR) of X per cent over the course of the evaluation period, reaching a market capitalization of USD XX million over the course of the year 2027. By 2027, the European pemphigus demand is anticipated to have reached a value of USD XX million.
According to the reports, In order to better understand the worldwide pemphigus market, it has been divided into five categories: kinds, diagnosis, therapy, end-users, and regions. On the basis of the kinds of pemphigus, the market is further subdivided into the following categories: paraneoplastic pemphigus. Pemphigus foliaceus, pemphigus vulgaris, and pemphigus vegetans. In terms of diagnosis, the industry has been divided into the following categories: skin biopsy, skin peeling, blood testing, and endoscopy.
The market has been categorized according to treatment into corticosteroids, initial therapy, and maintenance therapy. Immunosuppressive drugs, biological treatments, intravenous immunoglobulin (IVIG) therapy, and other medications are used to treat the condition. The end-user market is divided into four categories: academic and research organizations, hospitals and clinics, labs, and others.
The pemphigus market has been classified into four regions: the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The pemphigus market in the Americas has been further classified into North America and South America, with the US and Canada constituting the North American market. Western Europe and Eastern Europe comprise the European pemphigus market. Western Europe is further subdivided into the United Kingdom, Germany, Italy, France, Spain, and the rest of Western Europe.
The Asia-Pacific pemphigus market has been classified as follows: India, Japan, China, Australia, South Korea, and the rest of Asia-Pacific. The Middle East & Africa pemphigus market has been split into the Middle East and Africa.
The market is segmented based on the kinds, diagnosis, therapy, end-users, and regions. The global pemphigus market trends is expected to witness decent growth during the forecast period.
The Application is segmented into corticosteroids, initial therapy, and maintenance therapy. Immunosuppressive drugs, biological treatments, intravenous immunoglobulin (IVIG) therapy, and other medications.
The market is segmented into academic and research organizations, hospitals and clinics, labs, and others based on the propulsion types.
According to the reports, the pemphigus market has been broken down into the Americas, Europe, Asia-Pacific, and the Middle East & Africa regions by geography. Due to the rising number of older populations, increased government spending on dental hygiene, the availability of disposable money and the rising use of tobacco in Europe, Europe is predicted to be the 2nd biggest pemphigus market share in the world. In the year 2017, occurrences of pemphigus documented by the Europe PMC ranged from 0.5 instances per million inhabitants in Germany to 8 occurrences per million population in Greece, with a total of 1.6,16.1.
Pemphigus and other dental health issues are developing in emerging nations, where people have more disposable money and can afford to spend more on healthcare coverage. Emerging economies in the Middle East and Africa are predicted to have the smallest share of the worldwide pemphigus market outlook due to lack of expansion, lack of technological understanding, and insufficient healthcare centres.
Several participants in the worldwide pemphigus market have shown a strong interest in advancing their prospects by strategically improving their competitive position.
Report Overview
The following report comprises of –
Recent Developments
Global Pemphigus Market, by Pemphigus Types
Global Pemphigus Market, by Diagnosis
Global Pemphigus Market, by Treatment
Global Pemphigus Market, by End User
Global Pemphigus Market, by Region
| Report Attribute/Metric | Details |
| Market Size (2032) | 3.21 Billion |
| CAGR | 7.57% |
| Base Year | 2022 |
| Forecast Period | 2032 |
| Historical Data | 2021 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Types, Diagnosis, Treatment, And End Users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Novartis Pharmaceuticals, Hoffmann-La Roche, Principia Biopharma, Inc, Argenx, Sanofi S.A., Pfizer Inc., Teligent Inc, GlaxoSmithKline LLC, Teva Pharmaceutical Industries. |
| Key Market Opportunities | · Healthcare expenditure · Research and development |
| Key Market Drivers | · Increasing prevalence of cancer, consumption of tobacco, unhealthy lifestyle · Increasing geriatric population and increasing awareness for oral hygiene |
Pemphigus Market Highlights:
Frequently Asked Questions (FAQ) :
Pemphigus is a group of rare autoimmune skin disorders that cause blisters, sores on the skin, in the mouth, or on the genitals.
The market is expected to exhibit a strong 7.35% CAGR over the forecast period from 2023-2032.
The increasing prevalence of cancer is likely to be a major driver for the Pemphigus Market over the forecast period.
Americas are anticipated to dominate the global Pemphigus Market.
Leading players in the market include Novartis, Principia Biopharma, and Pfizer, among others.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
